Precision Medicine

Scalable commercialization support spanning from early strategy through execution

Precision Medicine plays a vital role in identifying appropriate patients for new targeted therapies across multiple specialties. Amplity has unique experience and expertise in developing launch strategies – aligning, optimizing and operationalizing the commercial components of a diagnostic to your therapy. We’ve supported Companion Diagnostic launches across 20 indications, 10 tumor types, and multiple methodologies.

Our flexible, global solutions help eliminate operational barriers around testing, create advocacy for your therapy, and mobilize the multi-disciplinary process to drive behavior change.

Here’s how we can help:

Virtual Diagnostic Center

A global resource for strategic planning, the VDC quantifies specific, account level detail to optimize development and launch strategies

Laboratory Science Liaisons

Increase disease state awareness and collect meaningful insights, and support quality testing initiatives with dedicated non-promotional laboratory specialist teams

Companion Diagnostic Commercialization

Our Precision Medicine experts have created an eco-system that focuses specifically on delivering operational elements required for optimal companion diagnostic market execution.

Consulting Services

Hands on, end-to-end advisory services to support planning and executional strategy

Oncology Diagnostic Manager

Dedicated promotional field commercial teams focused on laboratory medical specialists to optimize operational components of testing

Answering the big questions associated when launching a Companion Diagnostic

Amplity’s VP of Precision Medicine and Companion Diagnostics, Ken Ruppel, discusses the four simple areas that must be considered when launching a precision medicine therapy: why, when, what, and who.

Learn More

It’s Time to Embrace Companion Diagnostics to Accelerate Precision Medicine

Read our white paper for a quick history on the challenges aligning a diagnostic to a therapy has created for Pharma along with a few suggestions on how to improve the process.

Learn More

Maximizing Launch Effectiveness

Amplity’s Precision Medicine team provides expertise throughout the product life cycle, including but not limited to consultative support, medical affairs, commercial and Key Opinion Leader (KOL) networks. Our deep relationships with National and Regional Reference laboratories and University and Community pathologists create instant access to key players in the multidisciplinary process-pre and post-launch. Our colleagues amplify your diagnostic strategy and execution, optimizing your therapeutic launch.

Commercializing a Companion Diagnostic

Our Precision Medicine experts have created an eco-system that focuses specifically on delivering operational elements required for optimal companion diagnostic market execution.

We have supported successful Companion Diagnostic launches across several tumor types, disease states, and methodologies. As a result, we have first-hand evidence proving that when a diagnostic and therapy are aligned, therapeutic uptake is accelerated.

Interested in learning more? Click here for a case study on how our Laboratory Science Liaisons supported testing a novel biomarker for a new Companion Diagnostic.